Articles and Blogs

On April 17, 2025, the Centers for Medicare & Medicaid Services (“CMS”) extended the due date to complete and submit the new Form CMS-855A SNF Disclosures Attachment for every Skilled Nursing Facility (“SNF”). In its Medicare Learning Network, 2025-04-17-MLNC, CMS formally announced that enrolled skilled nursing facilities should collect data on ownership, managerial and related party information…Read More

The Food and Drug Administration’s (“FDA”) Office of Prescription Drug Promotion (“OPDP”) started 2025 with two Untitled Letters, one in February and one in March, potentially signaling more enforcement for the year. OPDP issued only five enforcement letters in 2023 and 2024, with a heavy focus on influencer marketing. However, on April 1, 2025, most…Read More

Health care continues to drive private equity (“PE”) activity, creating opportunities for investors and traditional health care providers. Transactions in the health care space are especially complicated, layering health care regulatory and reimbursement considerations on top of a complex securities, antitrust, privacy and security framework. Hall Render’s PE team of attorneys and advisors leverage the…Read More

We are taking a break from our regular briefing this week to focus on a list of trends we are seeing in the market. Take a look at our list—if we didn’t cover a trend you are seeing in the market, send us a note. We always enjoy hearing from our readers. As always, if…Read More

On February 7, 2025, legislators introduced Washington State House Bill 1881 and its companion bill, Senate Bill 5704 (collectively, the “Bills”), to enhance oversight and regulation of material changes within the state’s health care marketplace. The Bills’ primary stated objectives are to ensure that health care transactions do not adversely affect the accessibility, affordability and…Read More

Health care continues to drive private equity (“PE”) activity, creating opportunities for investors and traditional health care providers. Transactions in the health care space are especially complicated, layering health care regulatory and reimbursement considerations on top of a complex securities, antitrust, privacy and security framework. Hall Render’s PE team of attorneys and advisors leverage the…Read More

On January 14, 2025, the Wage and Hour Division of the Department of Labor (“DOL”) issued two opinion letters. One of the letters, FMLA 2025-1-A (“Opinion Letter”), provided guidance on the application of federal Family and Medical Leave Act (“FMLA”) regulations to paid leave employees take under state and local government family and medical leave…Read More

On February 12, 2025, the Texas House of Representatives (“House”) introduced House Bill 2747 (“H.B. 2747”), which would require entities to report certain health care transactions to the Texas Attorney General (“AG”). If passed, H.B. 2747 would go into effect on September 1, 2025, adding Texas to the growing list of states exercising increased oversight…Read More

In United States ex rel. Feliciano v. Ardoin, a pro se relator filed a qui tam action under the False Claims Act (“FCA”). On February 4, 2025, the D.C. Court of Appeals (the “Court”) affirmed a district court’s dismissal ruling that a pro se litigant cannot allege violations of the FCA. In doing so, the…Read More